Abstract | Background: The receptors of salmon calcitonin, located on certain areas of the brain such as the periaqueductal gray matter, are responsible for pain modulation. Aims: The effects of intracerebroventricular injection of salmon calcitonin on the behavioral response to pain and on the levels of monoamines in the periaqueductal gray were explored using a biphasic animal model of pain. Study Design: Animal experiment. Methods: A total of 45 male rats were divided into four groups (n=6). Salmon calcitonin was injected into the lateral ventricle of the brain (1.5 nmol, with a volume of 5 μL). After 20 min, 2.5% formalin was subcutaneously injected into the right leg claw, and pain behavior was recorded on a numerical basis. At the time of the formalin test, the periaqueductal gray area was microdialized. High-performance liquid chromatography method was used to gauge the levels of monoamines and their metabolites. Results: Conclusion:
Salmon calcitonin reduced pain by increasing the concentrations of monoamines and the metabolites derived from them in the periaqueductal gray area.
|
Authors | Kaveh Rahimi, Javad Sajedianfard, Ali Akbar Owji |
Journal | Balkan medical journal
(Balkan Med J)
Vol. 36
Issue 5
Pg. 263-269
(08 22 2019)
ISSN: 2146-3131 [Electronic] Turkey |
PMID | 31218879
(Publication Type: Journal Article)
|
Chemical References |
- Biogenic Monoamines
- Calcitonin
|
Topics |
- Analysis of Variance
- Animals
- Biogenic Monoamines
(analysis, physiology)
- Calcitonin
(administration & dosage, pharmacology)
- Pain Measurement
(methods)
- Periaqueductal Gray
(chemistry, pathology)
- Rats
- Rats, Sprague-Dawley
(metabolism, physiology)
- Salmon
(blood, physiology)
|